New patent expiration for Novartis drug AMTURNIDE

Annual Drug Patent Expirations for AMTURNIDE Amturnide is a drug marketed by Novartis and is included in one NDA. There is one patent protecting this drug. This drug has twenty-nine…

The post New patent expiration for Novartis drug AMTURNIDE appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.